AUROBINDO PHARMA LTD FDA Approval ANDA 211816

ANDA 211816

AUROBINDO PHARMA LTD

FDA Drug Application

Application #211816

Application Sponsors

ANDA 211816AUROBINDO PHARMA LTD

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTION25MG/ML0CHLORPROMAZINE HYDROCHLORIDECHLORPROMAZINE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2020-07-07STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAP

CDER Filings

AUROBINDO PHARMA LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 211816
            [companyName] => AUROBINDO PHARMA LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"CHLORPROMAZINE HYDROCHLORIDE","activeIngredients":"CHLORPROMAZINE HYDROCHLORIDE","strength":"25MG\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"07\/07\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-07-07
        )

)

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.